<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">lvrach</journal-id><journal-title-group><journal-title xml:lang="ru">Лечащий Врач</journal-title><trans-title-group xml:lang="en"><trans-title>Lechaschi Vrach</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1560-5175</issn><issn pub-type="epub">2687-1181</issn><publisher><publisher-name>ООО «Издательство "Открытые системы"»</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.51793/OS.2026.29.6.003</article-id><article-id custom-type="elpub" pub-id-type="custom">lvrach-1637</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ГИНЕКОЛОГИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>GYNECOLOGY</subject></subj-group></article-categories><title-group><article-title>Особенности патогенетической терапии и профилактики рецидивирующей инфекции нижних мочевых путей в постклимактерии</article-title><trans-title-group xml:lang="en"><trans-title>Features of pathogenetic therapy and prevention of recurrent lower urinary tract infections in postmenopausal women</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-1138-1174</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Нашивочникова</surname><given-names>Н. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Nashivochnikova</surname><given-names>N. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Нашивочникова Наталья Алексеевна, к.м.н., доцент кафедры урологии имени Е. В. Шахова</p><p>603950, Нижний Новгород, пл. Минина и Пожарского, 10/1</p></bio><bio xml:lang="en"><p>Natalya A. Nashivochnikova, Cand. of Sci. (Med.), Associate Professor of the Department of Urology named after E. V. Shakhov</p><p>10/1 Minin and Pozharsky Square, Nizhny Novgorod, 603950</p></bio><email xlink:type="simple">dom17.doctor@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-4887-4888</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Крупин</surname><given-names>В. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Krupin</surname><given-names>V. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Крупин Валентин Николаевич, д.м.н., професор, заведующий кафедрой кафедры урологии имени Е. В. Шахова</p><p>603950, Нижний Новгород, пл. Минина и Пожарского, 10/1</p></bio><bio xml:lang="en"><p>Valentin N. Krupin, Dr. of Sci. (Med.), Professor, Head of the Department of Urology named after E.V. Shakhov</p><p>10/1 Minin and Pozharsky Square, Nizhny Novgorod, 603950</p></bio><email xlink:type="simple">urolog@pimunn.net</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-9934-3868</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Зубова</surname><given-names>С. Ю.</given-names></name><name name-style="western" xml:lang="en"><surname>Zubova</surname><given-names>S. Yu.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Зубова Светлана Юрьевна, врач ультразвуковой диагностики</p><p>603093, Нижний Новгород, ул. Родионова, 190</p></bio><bio xml:lang="en"><p>Svetlana Yu. Zubova, Ultrasound Physician, State Budgetary Healthcare Institution of the Nizhny Novgorod region</p><p>190 Rodionova str., Nizhny Novgorod, 603093</p></bio><email xlink:type="simple">zubova.svetlana.65@yandex.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-7653-797X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Леанович</surname><given-names>В. Е.</given-names></name><name name-style="western" xml:lang="en"><surname>Leanovich</surname><given-names>V. E.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Леанович Виктория Егурбиевна, медицинский директор</p><p>123112, Москва, наб. Пресненская, 8, стр. 1, помещен.11Н/8 «Москва»</p></bio><bio xml:lang="en"><p>Viktoriya E. Leanovich, Medical Director</p><p>room 11N/8 "Moscow" 8, bld. 1, nab. Presnenskaya, Moscow, 123112</p></bio><email xlink:type="simple">leanovichVE@akvion.ru</email><xref ref-type="aff" rid="aff-3"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Приволжский исследовательский медицинский университет</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Privolzhsky Research Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Нижегородская областная клиническая больница им. Н. А. Семашко</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Regional Clinical Hospital named after N. A. Semashko</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-3"><aff xml:lang="ru"><institution>Акционерное общество «Аквион»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Akvion Joint Stock Company</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2026</year></pub-date><pub-date pub-type="epub"><day>01</day><month>07</month><year>2026</year></pub-date><volume>0</volume><issue>6</issue><fpage>21</fpage><lpage>29</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Нашивочникова Н.А., Крупин В.Н., Зубова С.Ю., Леанович В.Е., 2026</copyright-statement><copyright-year>2026</copyright-year><copyright-holder xml:lang="ru">Нашивочникова Н.А., Крупин В.Н., Зубова С.Ю., Леанович В.Е.</copyright-holder><copyright-holder xml:lang="en">Nashivochnikova N.A., Krupin V.N., Zubova S.Y., Leanovich V.E.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://journal.lvrach.ru/jour/article/view/1637">https://journal.lvrach.ru/jour/article/view/1637</self-uri><abstract><p>Введение. Частота встречаемости урогенитальных расстройств у женщин 55-70 лет достигает 30-75%. Это комплекс вагинальных и мочевых симптомов, развитие которых является осложнением возрастных процессов в эстроген-зависимых тканях и структурах нижних мочевых путей и полового тракта.Цель работы. Изучение эффективности биологически активной добавки, содержащей комплекс натуральных растительных веществ – D-маннозу, проантоцианидины клюквы типа А и витамин С, у пациенток с рецидивирующей инфекцией нижних мочевых путей в период постменопаузы.Материалы и методы. В исследование были включены 90 пациенток в постменопаузе с рецидивирующей инфекцией мочевых путей. Основную группу составили 46, контрольную – 44 пациентки (средний возраст – 59,3 ± 5,3 года). Пациенткам основной группы назначалась антимикробная терапия при обострении (фосфомицина трометамол в дозе 3 г однократно) + биологически активная добавка Цистениум II, содержащая комплекс натуральных растительных веществ (по 1 таблетке 2 раза в день во время еды в течение 3 месяцев). Пациентки контрольной группы получали стандартную антимикробную терапию в случае обострения инфекции мочевых путей. Результаты оценивали через 1 месяц от начала терапии и спустя 6 месяцев.Результаты исследования. Все пациентки основной группы (n = 46), у которых совместно с противомикробной терапией в период обострения инфекции использовалась биологически активная добавка, содержащая комплекс натуральных растительных веществ, отмечали значительное улучшение как общего самочувствия, так и локальных симптомов не только при визитах через 1 месяц после начала приема препарата, но и во время всего срока наблюдения в течение 6 месяцев. В результате активного противовоспалительного и протективного действия, наличия сосудистых эффектов компонентов биологически активной добавки улучшилось не только общее состояние пациенток, по данным лазерной допплеровской флоуметрии отмечена положительная динамика на уровне микроциркуляции тканей стенки мочевого пузыря и уретры и, как показывают данные проведенной ультразвуковой допплерографии, уменьшился венозный застой в органах малого таза и парауретральном сплетении. Применение биологически активной добавки позволило не только значительно снизить показатель бессимптомной бактериурии среди женщин основной группы, но и количество рецидивов цистита за 6 месяцев наблюдения от начала терапии. Важным предрасполагающим фактором развития рецидивирующей инфекции мочевых путей у женщин в постклимактерии является состояние гормонального фона, способствующее метаболическим и локальным иммунным изменениям, а также расстройству гемодинамики малого таза в целом. Адекватное кровоснабжение, в том числе и венозное, также является одной из главных предпосылок нормальной функциональной деятельности слизистой оболочки урогенитальной зоны и мочевого пузыря. Активные компоненты, входящие в состав биологически активной добавки, не только способствуют улучшению состояния гемодинамики мочевого пузыря и уретры, но и оказывают защитное, противовоспалительное действие, на что указывает уменьшение числа рецидивов инфекций мочевых путей в 4 раза у пациенток основной группы за 6 месяцев наблюдения.Заключение. Полученные результаты свидетельствуют о высокой терапевтической эффективности биологически активной добавки, содержащей комплекс натуральных растительных веществ, как в комплексной терапии, так и в профилактике рецидивов инфекций нижних мочевых путей у пациенток, в том числе в период постменопаузы.</p></abstract><trans-abstract xml:lang="en"><p>Background. The incidence of urogenital disorders in women aged 55-70 years reaches 30-75%. This is a complex of vaginal and urinary symptoms, the development of which is a complication of age-related processes in estrogen-dependent tissues and structures of the lower urinary tract and reproductive tract.Objective. To study the effectiveness of the dietary supplement, containing a complex of natural plant substances – D-mannose, cranberry type A proanthocyanidins and vitamin C, in patients with recurrent lower urinary tract infections during the postmenopausal period.Materials and methods. The study included 90 postmenopausal patients with recurrent urinary tract infection. The main group consisted of 46 patients, the control group – 44 patients (average age 59.3 ± 5.3 years). Patients of the main group were prescribed antimicrobial therapy for exacerbations (fosfomycin trometamol in a dose of 3 g once) + dietary supplement Cystenium II, containing a complex of natural plant substances, which was used 1 tablet 2 times a day with meals for 3 months. Patients in the control group received standard antimicrobial therapy in case of exacerbation of urinary tract infection. The results were assessed 1 month after the start of therapy and 6 months later.Results. During the study, all patients of the main group (46 women), who used the Cystenium II dietary supplement as part of treatment, together with antimicrobial therapy during an exacerbation of infection, noted a significant improvement in both general well-being and local symptoms not only at visits 1 month after the start of taking the drug, but also during the entire observation period after 6 months. As a result of the active anti-inflammatory, protective action, and the presence of vascular effects of the components of the dietary supplement, not only the general condition of the patients improved, according to LDF data, positive dynamics were noted at the level of microcirculation of the tissues of the bladder wall and urethra and, as shown by ultrasound Dopplerography, venous congestion in the pelvic organs and paraurethral plexus is reduced. The use of the dietary supplement allowed not only to significantly reduce the rate of asymptomatic bacteriuria among women in the main group, but also the number of relapses of cystitis over 6 months of observation from the start of therapy. An important predisposing factor in the development of recurrent urinary tract infection in postmenopausal women is the state of the hormonal background, which entails metabolic, local immune changes, and disorder of pelvic hemodynamics as a whole. Adequate blood supply, including venous, is also one of the main prerequisites for the normal functional activity of the mucous membrane of the urogenital area and bladder. The active components included in the dietary supplement not only help improve the hemodynamics of the bladder and urethra, but also have a protective, anti-inflammatory effect, as evidenced by a 4-fold decrease in the number of urinary tract infection relapses in patients of the main group over 6 months of observation.Conclusion. The results obtained indicate the high therapeutic effectiveness of the dietary supplement, containing a complex of natural plant substances, both for complex therapy and for the prevention of relapses of lower urinary tract infections in patients, including during the postmenopausal period.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>цистит</kwd><kwd>рецидив</kwd><kwd>постменопауза</kwd><kwd>проантоцианидины клюквы типа А</kwd><kwd>D-манноза</kwd></kwd-group><kwd-group xml:lang="en"><kwd>cystitis</kwd><kwd>relapse</kwd><kwd>postmenopause</kwd><kwd>cranberry type A proanthocyanidins</kwd><kwd>D-mannose</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Panay N. Genitourinary syndrome of the menopause – dawn of a new era? Climacteric. 2015; 18 (Suppl_1): 13-17. https://doi.org/10.3109/13697137.2015.1070564.</mixed-citation><mixed-citation xml:lang="en">Panay N. Genitourinary syndrome of the menopause – dawn of a new era? Climacteric. 2015; 18 (Suppl_1): 13-17. https://doi.org/10.3109/13697137.2015.1070564.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Ермакова Е. И., Балан В. Е., Тихомирова Е. В., Лазарева И. Н., Лапина А. В., Панина Е. М. Генитоуринарный менопаузальный синдром: диагностика и принципы лечения (краткие клинические рекомендации). Российский вестник акушера-гинеколога. 2017; 17 (6): 89 95.</mixed-citation><mixed-citation xml:lang="en">Ermakova E. I., Balan V. E., Tikhomirova E. V., Lazareva I. N., Lapina A. V., Panina E. M. Genitourinary syndrome of menopause: diagnosis and principles of treatment (brief clinical guidelines). Rossiiskii vestnik akushera-ginekologa. 2017; 17 (6): 89 95. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Балан В. Е., Синякова Л. А., Богдашевская О. В. Нарушения биотипа влагалища в разные периоды жизни женщины: связь с дизурическими расстройствами. Взгляд гинеколога и уролога на причины и принципы лечения генитоуринарных расстройств. Под ред. В. Е. Радзинского. М.: Редакция журнала Status Praesens, 2018. 20 c.</mixed-citation><mixed-citation xml:lang="en">Balan V. E., Sinyakova L. A., Bogdashevskaya O. V. Disturbances of the vaginal biotope at different periods of a woman’s life: association with urinary disorders. A view of a gynecologist and urologist on the causes and principles of treatment of genitourinary disorders. Ed. by V. E. Radzinskii. M.: Editorial Board of Status Praesens journal, 2018, p. 20. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Слесаревская М. Н., Кузьмин И. В., Жумадиллаев К. Г., Введенский Г. А., Михеев Ю. А., Максимова А. В. Микробиом и микробиота мочи: современные представления и гендерные особенности. Урологические ведомости. 2022; 2 (12): 157-165. DOI: https://doi.org/10.17816/uroved109278.</mixed-citation><mixed-citation xml:lang="en">Slesarevskaya M. N., Kuzmin I. V., Zhumadillaev K. G., Vvedenskii G. A, Mikheev Yu. A., Maksimova A. V. Microbiome and urine microbiota: modern concepts and gender features. Urologicheskie vedomosti. 2022; 2 (12): 157-165. (In Russ.) DOI: https://doi.org/10.17816/uroved109278.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Sekirov I., Russell S. L., Antunes L. C. M., Finlay B. B. Gut microbiota in health and disease. Physiol Rev. 2010; 90: 859-904. DOI: 10.1152/physrev.00045.2009.</mixed-citation><mixed-citation xml:lang="en">Sekirov I., Russell S. L., Antunes L. C. M., Finlay B. B. Gut microbiota in health and disease. Physiol Rev. 2010; 90: 859-904. DOI: 10.1152/physrev.00045.2009.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Gasiorek M., Hsieh M. H., Forster C. S. Utility of DNA Next-Generation Sequencing and Expanded Quantitative Urine Culture in Diagnosis and Management of Chronic or Persistent Lower Urinary Tract Symptoms. J Clin Microbiol. 2019; 58: e00204-e002019. DOI: 10.1128/JCM.00204-19.</mixed-citation><mixed-citation xml:lang="en">Gasiorek M., Hsieh M. H., Forster C. S. Utility of DNA NextGeneration Sequencing and Expanded Quantitative Urine Culture in Diagnosis and Management of Chronic or Persistent Lower Urinary Tract Symptoms. J Clin Microbiol. 2019; 58: e00204-e002019. DOI: 10.1128/JCM.00204-19.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Global Prevalence of Urinary Tract Infections in the Older Persons: A Systematic Review and Meta-Analysis 2024.</mixed-citation><mixed-citation xml:lang="en">Global Prevalence of Urinary Tract Infections in the Older Persons: A Systematic Review and Meta-Analysis 2024.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Gu Y. , Zhou G., Zhou F., et a. Gut and Vaginal Microbiomes in PCOS:</mixed-citation><mixed-citation xml:lang="en">Implications for Women's Health. FrontEndocrinol 2022: 13: 808508. DOI: 3389/fendo.2022.808508. eCollection2022.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Elkafas H., Walls M., Al-Hendy A., Ismail N. Gut and genital tract microbiomes: Dysbiosis and link to gynecological disorders. Front Cell Infect Microbiol. 2022; 12: 1059825. DOI: 10.3389/fcimb.2022.1059825. eCollection 2022.</mixed-citation><mixed-citation xml:lang="en">Elkafas H., Walls M., Al-Hendy A., Ismail N. Gut and genital tract microbiomes: Dysbiosis and link to gynecological disorders. Front Cell Infect Microbiol. 2022; 12: 1059825. DOI: 10.3389/fcimb.2022.1059825. eCollection 2022.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Graziottin A in: Studd J., Seang L. T., Chervenak F. A. (Eds); Current Progress in Obstetrics and Gynaecology. 2014; 2: 319-336. Saliba W. et al. Eur J Intern Med. 2013; 24 (2): 127-131.</mixed-citation><mixed-citation xml:lang="en">Graziottin A in: Studd J., Seang L. T., Chervenak F. A. (Eds); Current Progress in Obstetrics and Gynaecology. 2014; 2: 319-336. Saliba W. et al. Eur J Intern Med. 2013; 24 (2): 127-131.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Тапильская Н. И., Миронова А. В., Силаева Е. А., Шкарупа А. В., Глушаков Р. И. Синдром хронической тазовой боли у женщин: факторы риска, алгоритмы дифференциальной диагностики, лечения и профилактики. Проблемы репродукции. 2021; 27 (2): 56-64.</mixed-citation><mixed-citation xml:lang="en">Tapilskaya N. I., Mironova A. V., Silaeva E. A., Shkarupa A. V., Glushakov R. I. Chronic pelvic pain syndrome in women: risk factors, differential diagnosis, treatment and prevention. Problemy reproduktsii. 2021; 27 (2): 56-64. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Зайцев А. В., Шаров М. Н., Арефьева О. А., Пушкарь Д. Ю. Синдром болезненного мочевого пузыря/интерстициальный цистит: факторы прогноза клинического течения заболевания. Вестник урологии. 2018; 6 (3): 26-35. DOI: 10.21886/2308-6424-2017-6-3-26-35.</mixed-citation><mixed-citation xml:lang="en">Zaytsev A. V., Sharov M. N., Arefeva O. A., Pushkar D. Yu. Interstitial Cystitis Bladder Pain Syndrome: factors predicting the clinical course of the disease. Vestnik urologii. 2018; 6 (3): 26-35. (In Russ.) DOI: 10.21886/2308-6424-2017-6-3-26-35.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Шарипова К. К., Гатин Р. Ф., Айдарбекова А. С., Сулейменов К. Г. Расстройства мочеиспускания у женщин в климактерии. Экспериментальная и клиническая медицина. 2018; раздел 1: 47-52.</mixed-citation><mixed-citation xml:lang="en">Sharipova K. K., Gatin R. F., Aydarbekova A. S., Suleymenov K. G. Urination disorders in women in climacteria. Eksperimentalnaya i klinicheskaya meditsina. 2018; 47-52. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Dominoni M., Scatigno A.L., La Verde M., et al. Microbiota Ecosystem in Recurrent Cystitis and the Immunological Microenvironment of Urothelium. Healthcare. 2023; 11 (4): 525. DOI: 10.3390/healthcare11040525.</mixed-citation><mixed-citation xml:lang="en">Dominoni M., Scatigno A.L., La Verde M., et al. MicrobiotaEcosystem in Recurrent Cystitis and the Immunological Microenvironment of Urothelium. Healthcare. 2023; 11 (4): 525. DOI: 10.3390/healthcare11040525.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Murray B. E., Rensimer E. R., DuPont H. L. Emergence of high-level trimethoprim resistance in fecal Escherichia coli during oral administration of trimethoprim or trimethoprim –sulfamethoxazole. N Engl J Med. 1982; 306: 130-135. DOI: 10.1056/NEJM198201213060302.</mixed-citation><mixed-citation xml:lang="en">Murray B. E., Rensimer E. R., DuPont H. L. Emergence of high-level trimethoprim resistance in fecal Escherichia coli during oral administration of trimethoprim or trimethoprim –sulfamethoxazole. N Engl J Med. 1982; 306: 130-135. DOI: 10.1056/NEJM198201213060302.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Al-Ghazzewi F. H., Tester R. F. Biotherapeutic agents and vaginal health. J Appl Microbiol. 2016; 121: 18-27. DOI: 10.1111/jam.13054.</mixed-citation><mixed-citation xml:lang="en">Al-Ghazzewi F. H., Tester R. F. Biotherapeutic agents and vaginal health. J Appl Microbiol. 2016; 121: 18-27. DOI: 10.1111/jam.13054.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Reid G. The development of probiotics for women's health. Can J Microbiol. 2017; 63: 269-277. DOI: 10.1139/cjm-2016-0733.</mixed-citation><mixed-citation xml:lang="en">Reid G. The development of probiotics for women's health. Can J Microbiol. 2017; 63: 269-277. DOI: 10.1139/cjm-2016-0733.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Ocipinti A., Germano A., Maffei M. E. Prevention of urinary tract infections with Urocran, a cranberry extract with a high content of A-type proanthocyanidins: a preclinical double-blind controlled study. Urol J. 2016; 13: 2640-2649.</mixed-citation><mixed-citation xml:lang="en">Ocipinti A., Germano A., Maffei M. E. Prevention of urinary tract infections with Urocran, a cranberry extract with a high content of A-type proanthocyanidins: a preclinical double-blind controlled study. Urol J. 2016; 13: 2640-2649.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">González De Llano D., Liu H., Hu L., et al. Some insights into the antiadhesive activity of cranberry phenolics and their microbial metabolites against uropathogenic bacteria. J Agric Food Chem. 2019; 67: 2166-2174. DOI: 10.1021/acs.jafc.8b06274.</mixed-citation><mixed-citation xml:lang="en">González De Llano D., Liu H., Hu L., et al. Some insights into the antiadhesive activity of cranberry phenolics and their microbial metabolites against uropathogenic bacteria. J Agric Food Chem. 2019; 67: 2166-2174. DOI: 10.1021/acs.jafc.8b06274.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Sánchez-Patán F., Barroso E., van De Wiele T., et al. Comparative in vitro fermentation of cranberry and grape seed polyphenols with colonic microbiota. Food Chem. 2015; 183: 273-282. DOI: 10.1016/j.foodchem.2015.03.050.</mixed-citation><mixed-citation xml:lang="en">Sánchez-Patán F., Barroso E., van De Wiele T., et al. Comparative in vitro fermentation of cranberry and grape seed polyphenols with colonic microbiota. Food Chem. 2015; 183: 273-282. DOI: 10.1016/j.foodchem.2015.03.050.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Babar A., Moore L., Leblanc V., Dudonné S., Desjardins Y., Lemieux S., et al. High dose versus low dose standardized cranberry proanthocyanidin extract for the prevention of recurrent urinary tract infection in healthy women: a doubleblind randomized controlled trial. BMC Urol. 2021; 21 (1): 44. https://doi.org/10.1186/s12894-021-00811-w.</mixed-citation><mixed-citation xml:lang="en">Babar A., Moore L., Leblanc V., Dudonné S., Desjardins Y., Lemieux S., et al. High dose versus low dose standardized cranberry proanthocyanidin extract for the prevention of recurrent urinary tract infection in healthy women: a doubleblind randomized controlled trial. BMC Urol. 2021; 21 (1): 44. https://doi.org/10.1186/s12894-021-00811-w.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Fu Z., Liska D., Talan D., Chung M. Cranberry Reduces the Risk of Urinary Tract Infection Recurrence in Otherwise Healthy Women: A Systematic Review and Meta-Analysis. J Nutr 2017; 147 (12): 2282-2288. https://doi.org/10.3945/jn.117.254961.</mixed-citation><mixed-citation xml:lang="en">Fu Z., Liska D., Talan D., Chung M. Cranberry Reduces the Risk of Urinary Tract Infection Recurrence in Otherwise Healthy Women: A Systematic Review and Meta-Analysis. J Nutr 2017; 147 (12): 2282-2288. https://doi.org/10.3945/jn.117.254961.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Xia J. Yue, Yang C., Xu D. Feng, Xia H., Yang L. Gang, Sun G. Ju. Consumption of cranberry as adjuvant therapy for urinary tract infections in susceptible populations: A systematic review and meta-analysis with trial sequential analysis. PLoS One 2021; 16 (9): e0256992. https://doi.org/10.1371/journal.pone.0256992.</mixed-citation><mixed-citation xml:lang="en">Xia J. Yue, Yang C., Xu D. Feng, Xia H., Yang L. Gang, Sun G. Ju. Consumption of cranberry as adjuvant therapy for urinary tract infections in susceptible populations: A systematic review and meta-analysis with trial sequential analysis. PLoS One 2021; 16 (9): e0256992. https://doi.org/10.1371/journal.pone.0256992.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Williams G., Hahn D., Stephens J. H., Craig J. C., Hodson E. M. Cranberries for preventing urinary tract infections. Cochrane Database Syst Rev. 2023; 4 (4): CD001321. https://doi.org/10.1002/14651858.CD001321.pub6.</mixed-citation><mixed-citation xml:lang="en">Williams G., Hahn D., Stephens J. H., Craig J. C., Hodson E. M. Cranberries for preventing urinary tract infections. Cochrane Database Syst Rev. 2023; 4 (4): CD001321. https://doi.org/10.1002/14651858.CD001321.pub6.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Tamadonfar K. O., Omattage N. S., Spaulding C. N., Hultgren S. J. Reaching the end of the line: urinary tract infections. Microbiol Spectr. 2019; 7: 1-16. DOI: 10.1128/microbiolspec.UTI-0005-2012.</mixed-citation><mixed-citation xml:lang="en">Tamadonfar K. O., Omattage N. S., Spaulding C. N., Hultgren S. J. Reaching the end of the line: urinary tract infections. Microbiol Spectr. 2019; 7: 1-16. DOI: 10.1128/microbiolspec.UTI-0005-2012.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Rodríguez-Morató J., Matthan N. R., Liu J., et al. Cranberry consumption mitigates animal diet-induced changes in microbiota composition and functionality: a randomized crossover controlled feeding trial. J Nutr Biochem. 2018; 62: 76-86. DOI: 10.1016/j.jnutbio.2018.09.001.</mixed-citation><mixed-citation xml:lang="en">Rodríguez-Morató J., Matthan N. R., Liu J., et al. Cranberry consumption mitigates animal diet-induced changes in microbiota composition and functionality: a randomized crossover controlled feeding trial. J Nutr Biochem. 2018; 62: 76-86. DOI: 10.1016/j.jnutbio.2018.09.001.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Торшин И. Ю., Аполихина И. А., Громов А. Н., Громова О. А. Свойства D-маннозы: противовоспалительный и противоопухолевый эффекты. Экспериментальная и клиническая урология 2020; (2): 164-170.</mixed-citation><mixed-citation xml:lang="en">Torshin I. Yu., Apolikhina I. A., Gromov A. N., Gromova O. A. Concerning the properties of D-mannose: anti-inflammatory and antitumor effects. Eksperimentalnaya i klinicheskaya urologiya. 2020; (2): 164-170. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Громова О. А., Торшин И. Ю., Галустян А. Н., Сорокин А. И., Иванова М. И. Хемомикробиомный анализ синергизма D-маннозы и D-фруктозы в сравнении с молекулами других метабиотиков. Эффективная фармакотерапия. Урология и нефрология 2020; (2).</mixed-citation><mixed-citation xml:lang="en">Gromova O. A., Torshin I. Yu., Galustyan A. N., Sorokin A. I., Ivanova M. I. Chemomicrobiome analysis of the synergism of D-mannose and D-fructose compared with molecules of other metabiotics. Effektivnaya farmakoterapiya. Urologiya i nefrologiya. 2020; (2). (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Dalziel M., Crispin M., Scanlan C. N., Zitzmann N., Dwek R. A. Emerging principles for the therapeutic exploitation of glycosylation. Science. 2014; 343 (6166): 1235681. DOI: 10.1126/science.1235681.</mixed-citation><mixed-citation xml:lang="en">Dalziel M., Crispin M., Scanlan C. N., Zitzmann N., Dwek R. A. Emerging principles for the therapeutic exploitation of glycosylation. Science. 2014; 343 (6166): 1235681. DOI: 10.1126/science.1235681.</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Громова О. А., Торшин И. Ю., Тетруашвили Н. К. Систематический анализ исследований по D-маннозе и перспективы ее применения при рецидивирующих инфекциях мочеполовых путей у женщин репродуктивного возраста. Акушерство. Гинекология. Репродукция. 2019; 13 (2): 119-131. DOI: 10.17749/2313-7347.2019.13.2.119-131.</mixed-citation><mixed-citation xml:lang="en">Gromova O. A., Torshin I. Yu., Tetruashvili N. K. A systematic analysis of research on D-mannose and the prospects for its use in recurrent urinary tract infections in women of reproductive age. Akusherstvo. Ginekologiya. Reproduktsiya. 2019; 13 (2): 119-131. (In Russ.) DOI: 10.17749/2313-7347.2019.13.2.119-131.</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Kranz J., Bartoletti R., Bruyère F., et al. European Association of Urology Guidelines on Urological Infections: Summary of the 2024 Guidelines. Eur Urol. 2024; 86 (1): 27-41. DOI: 10.1016/j.eururo.2024.03.035.</mixed-citation><mixed-citation xml:lang="en">Kranz J., Bartoletti R., Bruyère F., et al. European Association of UrologyGuidelines on Urological Infections: Summary of the 2024 Guidelines. Eur Urol. 2024; 86 (1): 27-41. DOI: 10.1016/j.eururo.2024.03.035.</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Неймарк А. И., Шелковникова Н. В., Непомнящих Л. М., Давыдов А. В. Особенности хронического цистита, осложненного синдромом тазовой боли у женщин с варикозным расширением вен малого таза. Экспериментальная и клиническая урология. 2014; 4: 101-104.</mixed-citation><mixed-citation xml:lang="en">Neymark A. I., Shelkovnikova N. V., Nepomnyaschikh L. M., Davydov A. V. The peculiarities of chronic cystitis complicated with pelvic pain syndrome in women with varicose disease of the pelvic veins. Eksperimentalnaya i klinicheskaya urologiya. 2014; 4: 101-104. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Гус А. И., Семендяев А. А., Ступин Д. А., Черепанова М. А., Бачурина С. М., Селецкий А. Н., Колесникова Л. И. Профилактика рецидива варикозной болезни вен малого таза у женщин. Акушерство и гинекология. 2016; 10: 103-108.</mixed-citation><mixed-citation xml:lang="en">Gus A. I., Semendyaev A. A., Stupin D. A., Cherepanova M. A., Bachurina S. M., Seletskii A. N., Kolesnikova L. I. Prevention of recurrent varicose veins of the small pelvis in women. Akusherstvo i ginekologiya. 2016; 10: 103-108. (In Russ.)</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
